Streptomyces, the largest
genus of
Actinobacteria and type genus of the family
Streptomycetaceae. The current tally of the numbers of species is more than 500.
Streptomyces, along with other Actinobacteria, is a group containing
Gram-positive cell wall and
genomes with high
GC-content. Streptomycetes are found predominantly in
soil and in decaying vegetation, and most produce spores. Streptomycetes are noted for their distinct "earthy" odor which results from production of a volatile
metabolite,
geosmin.
Streptomycetes are characterised by a complex secondary metabolism. They produce over two-thirds of the clinically useful antibiotics of natural origin (e.g., neomycin, chloramphenicol). The now rarely-used streptomycin takes its name directly from Streptomyces. Streptomycetes are infrequent pathogens, though infections in human such as mycetoma can be caused by S. somaliensis and S. sudanensis and in plants such as scabies can be caused by S. caviscabies and S. scabies.
Genomics
The complete
genome of one of the strain, "
S. coelicolor" A3(2), was published in 2002. At the time, the "
S. coelicolor" genome was thought to contain the largest number of
genes of any
bacterium. The first complete genome sequence of
S. avermitilis was completed in 2003. Each of these genomes form a
chromosome with a linear structure, unlike most bacterial genomes which exist in the form of circular chromosomes. The genome sequence of
S. scabies, a member of the genus with the ability to cause potato scab disease, has been determined at the
Wellcome Trust Sanger Institute and is currently in annotation, with publication scheduled for 2007.
Taxonomically, "S. coelicolor" A3(2) belongs to the species of S. violaceoruber and not a validly described separate species; "S. coelicolor" A3(2) is not to be mistaken for S. coelicolor (Müller) (ATCC 23899).
Biotechnology
In recent years,
biotechnology researchers have begun to use
Streptomyces spp. for production of recombinant human proteins. Traditionally,
Escherichia coli was the species of choice to host
eukaryotic genes since it was well understood and easy to work with. However,
E. coli introduces problems such as incorrect (or lack of)
glycosylation and incorrect
protein folding, resulting in insolubility and loss of bioactivity of the product.
Streptomyces spp. on the other hand have the ability to secrete correctly folded
recombinant proteins into the medium after production simplifying the subsequent purification steps. These properties among others make
Streptomyces spp. an attractive alternative to other bacteria such as
E. coli and
Bacillus subtilis.
Medicine
Streptomyces is the largest
antibiotic producing genus, producing both antibacterials and
antifungals, and also a wide range of other
bioactive compounds such as
immunosuppressants
Some of the antifungals produced by Streptomyces spp.
Some of the antibiotics produced by Streptomyces spp.
Some of the Alkaloids produced by Streptomyces spp.
Some of the anti-cancer compounds produced by Streptomyces spp.
References
Further reading
- Baumberg S (1991). Genetics and Product Formation in Streptomyces. Kluwer Academic. ISBN 978-0306438851.
- Gunsalus IC (1986). Bacteria: Antibiotic-producing Streptomyces. Academic Press. ISBN 978-0123072092.
- Hopwood DA (2007). Streptomyces in Nature and Medicine: The Antibiotic Makers. Oxford University Press. ISBN 978-0195150667.
See also
External links